Hearing optimisation in neurofibromatosis type 2: A systematic review

Background It is common for patients with neurofibromatosis type 2 to develop bilateral profound hearing loss hearing loss, and this is one of the main determinants of quality of life in this patient group. Objectives The aim of this systematic review was to review the current literature regarding h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical otolaryngology 2017-12, Vol.42 (6), p.1329-1337
Hauptverfasser:	Lloyd, S.K.W., King, A.T., Rutherford, S.A., Hammerbeck‐Ward, C.L., Freeman, S.R.M., Mawman, D.J., O'Driscoll, M., Evans, D.G.
Format:	Artikel
Sprache:	eng
Schlagworte:	acoustic neuroma Bevacizumab Brain stem Case studies Cochlea Cochlear implants Data processing Decision making Genetic disorders Hearing loss Hearing Loss - diagnosis Hearing Loss - etiology Hearing Loss - therapy Humans Implantation Literature reviews Management Monoclonal antibodies Neurofibromatosis Neurofibromatosis 2 Neurofibromatosis 2 - complications Neurofibromatosis 2 - diagnosis Neurofibromatosis 2 - therapy Neurofibromin 2 Neurological disorders outcomes Patients Preservation Quality assessment Quality of life Radiation therapy Rehabilitation Searching sensorineural hearing loss Statistical analysis Surgery Surgical mesh systematic reviews Tumors Vestibular system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!